Skip to main content
Gut logoLink to Gut
. 1997 Mar;40(3):406–411. doi: 10.1136/gut.40.3.406

Colonic wall thickness measured by ultrasound: striking differences in patients with cystic fibrosis versus healthy controls.

H P Haber 1, N Benda 1, G Fitzke 1, A Lang 1, M Langenberg 1, J Riethmüller 1, M Stern 1
PMCID: PMC1027094  PMID: 9135533

Abstract

BACKGROUND: Colonic strictures represent an advanced stage of fibrosing colonopathy in patients with cystic fibrosis. AIMS: To clarify whether ultrasonography can identify patients with an early stage of fibrosing colonopathy and to determine clinical factors that influence bowel wall thickening. PATIENTS: Ninety patients with cystic fibrosis, median age 10 years, and 46 healthy controls, median age 13 years, were investigated. METHODS: Bowel wall thickness was measured by ultrasound in a prospective study. RESULTS: In cystic fibrosis, wall thickness of both small intestine and colon was significantly (p < 0.0001) higher than in controls; 81% of patients with cystic fibrosis had a maximum colon wall thickness at any site of 2 mm or more, a value that was never reached by controls. The maximum colon wall thickness was 6.5 mm. Bowel wall thickness was unchanged at re-examination after one year. There was no progression even with high dose pancreatic supplements. There was no association between bowel wall thickness and clinical features such as previous meconium ileus, intestinal resection, distal intestinal obstruction syndrome, abdominal pain, or pancreatic enzyme dose. CONCLUSIONS: There is genuine intestinal involvement in cystic fibrosis; in a few cases this could lead to fibrosing colonopathy.

Full text

PDF
406

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baxter P., Goldhill J., Hardcastle J., Hardcastle P. T., Taylor C. J. Enhanced intestinal glucose and alanine transport in cystic fibrosis. Gut. 1990 Jul;31(7):817–820. doi: 10.1136/gut.31.7.817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Borowitz D. S., Grand R. J., Durie P. R. Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. Consensus Committee. J Pediatr. 1995 Nov;127(5):681–684. doi: 10.1016/s0022-3476(95)70153-2. [DOI] [PubMed] [Google Scholar]
  3. Campbell C. A., Forrest J., Musgrove C. High-strength pancreatic enzyme supplements and large-bowel stricture in cystic fibrosis. Lancet. 1994 Jan 8;343(8889):109–110. [PubMed] [Google Scholar]
  4. Carty H. Abdominal radiology in cystic fibrosis. J R Soc Med. 1995;88 (Suppl 25):18–23. [PMC free article] [PubMed] [Google Scholar]
  5. Colombo C., Apostolo M. G., Ferrari M., Seia M., Genoni S., Giunta A., Sereni L. P. Analysis of risk factors for the development of liver disease associated with cystic fibrosis. J Pediatr. 1994 Mar;124(3):393–399. doi: 10.1016/s0022-3476(94)70361-2. [DOI] [PubMed] [Google Scholar]
  6. Eggermont E., De Boeck K. Small-intestinal abnormalities in cystic fibrosis patients. Eur J Pediatr. 1991 Oct;150(12):824–828. doi: 10.1007/BF01954999. [DOI] [PubMed] [Google Scholar]
  7. Freiman J. P., FitzSimmons S. C. Colonic strictures in patients with cystic fibrosis: results of a survey of 114 cystic fibrosis care centers in the United States. J Pediatr Gastroenterol Nutr. 1996 Feb;22(2):153–156. doi: 10.1097/00005176-199602000-00005. [DOI] [PubMed] [Google Scholar]
  8. Green M. R., Southern K. W., Wolfe S. P., Littlewood J. M., Najmaldin A. S., Wyatt J. I. Colonic strictures in cystic fibrosis. Arch Dis Child. 1995 Feb;72(2):191–191. doi: 10.1136/adc.72.2.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Guarner L., Rodríguez R., Guarner F., Malagelada J. R. Fate of oral enzymes in pancreatic insufficiency. Gut. 1993 May;34(5):708–712. doi: 10.1136/gut.34.5.708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Haber H. P., Lang A., Drews K., Stern M. Colonic wall thickening in cystic fibrosis identified by ultrasound. J Pediatr Gastroenterol Nutr. 1996 Nov;23(4):487–491. doi: 10.1097/00005176-199611000-00025. [DOI] [PubMed] [Google Scholar]
  11. Halter F., Weber B., Huber T., Eigenmann F., Frey M. P., Ruchti C. Diaphragm disease of the ascending colon. Association with sustained-release diclofenac. J Clin Gastroenterol. 1993 Jan;16(1):74–80. doi: 10.1097/00004836-199301000-00020. [DOI] [PubMed] [Google Scholar]
  12. Hata J., Haruma K., Suenaga K., Yoshihara M., Yamamoto G., Tanaka S., Shimamoto T., Sumii K., Kajiyama G. Ultrasonographic assessment of inflammatory bowel disease. Am J Gastroenterol. 1992 Apr;87(4):443–447. [PubMed] [Google Scholar]
  13. Jones R., Franklin K., Spicer R., Berry J. Colonic strictures in children with cystic fibrosis on low-strength pancreatic enzymes. Lancet. 1995 Aug 19;346(8973):499–499. [PubMed] [Google Scholar]
  14. Kimmey M. B., Martin R. W., Haggitt R. C., Wang K. Y., Franklin D. W., Silverstein F. E. Histologic correlates of gastrointestinal ultrasound images. Gastroenterology. 1989 Feb;96(2 Pt 1):433–441. doi: 10.1016/0016-5085(89)91568-0. [DOI] [PubMed] [Google Scholar]
  15. Kimmey M. B., Martin R. W., Haggitt R. C., Wang K. Y., Franklin D. W., Silverstein F. E. Histologic correlates of gastrointestinal ultrasound images. Gastroenterology. 1989 Feb;96(2 Pt 1):433–441. doi: 10.1016/0016-5085(89)91568-0. [DOI] [PubMed] [Google Scholar]
  16. Kimmey M. B., Wang K. Y., Haggitt R. C., Mack L. A., Silverstein F. E. Diagnosis of inflammatory bowel disease with ultrasound. An in vitro study. Invest Radiol. 1990 Oct;25(10):1085–1090. doi: 10.1097/00004424-199010000-00003. [DOI] [PubMed] [Google Scholar]
  17. Limberg B. Diagnosis of acute ulcerative colitis and colonic Crohn's disease by colonic sonography. J Clin Ultrasound. 1989 Jan;17(1):25–31. doi: 10.1002/jcu.1870170106. [DOI] [PubMed] [Google Scholar]
  18. Lloyd-Still J. D. Crohn's disease and cystic fibrosis. Dig Dis Sci. 1994 Apr;39(4):880–885. doi: 10.1007/BF02087437. [DOI] [PubMed] [Google Scholar]
  19. Mac Sweeney E. J., Oades P. J., Buchdahl R., Rosenthal M., Bush A. Relation of thickening of colon wall to pancreatic-enzyme treatment in cystic fibrosis. Lancet. 1995 Mar 25;345(8952):752–756. doi: 10.1016/s0140-6736(95)90639-8. [DOI] [PubMed] [Google Scholar]
  20. Mahony M. J., Corcoran M. High-strength pancreatic enzymes. Lancet. 1994 Mar 5;343(8897):599–600. [PubMed] [Google Scholar]
  21. Oades P. J., Bush A., Ong P. S., Brereton R. J. High-strength pancreatic enzyme supplements and large-bowel stricture in cystic fibrosis. Lancet. 1994 Jan 8;343(8889):109–109. [PubMed] [Google Scholar]
  22. Ong P. S., Oades P. J., Bush A., Brereton R. J. Colonic stricture in a boy with cystic fibrosis. Postgrad Med J. 1995 May;71(835):309–312. doi: 10.1136/pgmj.71.835.309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Prestridge L., Rogers B. B., Pritchard M., Hermann D., Megison S., Brown M. E., Prestidge C. Diffuse fibrosis of the colon complicating cystic fibrosis. J Pediatr Gastroenterol Nutr. 1996 Feb;22(2):219–224. doi: 10.1097/00005176-199602000-00016. [DOI] [PubMed] [Google Scholar]
  24. Regele S., Henker J., Münch R., Barbier Y., Stern M. Indirect parameters of pancreatic function in cystic fibrosis (CF) during a controlled double-blind trial of pancreatic supplementation. J Pediatr Gastroenterol Nutr. 1996 Jan;22(1):68–72. doi: 10.1097/00005176-199601000-00011. [DOI] [PubMed] [Google Scholar]
  25. Riccabona M., Rossipal E. Sonographic findings in celiac disease. J Pediatr Gastroenterol Nutr. 1993 Aug;17(2):198–200. doi: 10.1097/00005176-199308000-00012. [DOI] [PubMed] [Google Scholar]
  26. Smyth R. L., Ashby D., O'Hea U., Burrows E., Lewis P., van Velzen D., Dodge J. A. Fibrosing colonopathy in cystic fibrosis: results of a case-control study. Lancet. 1995 Nov 11;346(8985):1247–1251. doi: 10.1016/s0140-6736(95)91860-4. [DOI] [PubMed] [Google Scholar]
  27. Smyth R. L., van Velzen D., Smyth A. R., Lloyd D. A., Heaf D. P. Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes. Lancet. 1994 Jan 8;343(8889):85–86. doi: 10.1016/s0140-6736(94)90817-6. [DOI] [PubMed] [Google Scholar]
  28. Taylor C. J., Dodge J. A. High-strength pancreatic enzyme supplements and large-bowel stricture in cystic fibrosis. Lancet. 1994 Jan 8;343(8889):110–110. [PubMed] [Google Scholar]
  29. Taylor C. J., Steiner G. M. Fibrosing colonopathy in a child on low-dose pancreatin. Lancet. 1995 Oct 21;346(8982):1106–1107. doi: 10.1016/s0140-6736(95)91783-7. [DOI] [PubMed] [Google Scholar]
  30. Wesley A., Forstner J., Qureshi R., Mantle M., Forstner G. Human intestinal mucin in cystic fibrosis. Pediatr Res. 1983 Jan;17(1):65–69. doi: 10.1203/00006450-198301000-00013. [DOI] [PubMed] [Google Scholar]
  31. Worlicek H., Lutz H., Heyder N., Matek W. Ultrasound findings in Crohn's disease and ulcerative colitis: a prospective study. J Clin Ultrasound. 1987 Mar-Apr;15(3):153–163. doi: 10.1002/jcu.1870150302. [DOI] [PubMed] [Google Scholar]
  32. Zerin J. M., Kuhn-Fulton J., White S. J., Chong S. K., Stevens J. C., West K. W., Teitelbaum D. H., Nasr S. Z. Colonic strictures in children with cystic fibrosis. Radiology. 1995 Jan;194(1):223–226. doi: 10.1148/radiology.194.1.7997557. [DOI] [PubMed] [Google Scholar]
  33. de Jonge H. R. The molecular basis of chloride channel dysregulation in cystic fibrosis. Acta Paediatr Scand Suppl. 1989;363:14–19. doi: 10.1111/apa.1989.78.s363.14. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES